Multidrug-resistant tuberculosis (MDR-TB) presents an increasing threat to global tuberculosis
control. Many crucial management issues in MDR-TB treatment remain unanswered. We …

Background Multidrug-resistant tuberculosis threatens to reverse recent reductions in global
tuberculosis incidence. Although children younger than 15 years constitute more than 25% …

Background Tuberculous meningitis disproportionately affects young children. We aimed to
characterise treatment outcomes for this deadliest and most debilitating form of tuberculosis. …

Haiti is by all conventional criteria the poorest country in the western hemisphere and one of
the poorest in the world: 13 per capita gross national product (GNP) is around US $400; …

Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…

Background Extensively drug-resistant tuberculosis has been reported in 45 countries,
including countries with limited resources and a high burden of tuberculosis. We describe the …

Staphylococcus aureus and Escherichia coli sensitive to chloramphenicol incubated with this
antibiotic suffered oxidative stress with increase of anion superoxide (O 2 − ). This reactive …

Background Case fatality ratios in children with tuberculosis are poorly understood—particularly
those among children with HIV and children not receiving tuberculosis treatment. We …

To halt the global tuberculosis epidemic, transmission must be stopped to prevent new
infections and new cases. Identification of individuals with tuberculosis and prompt initiation of …

Background. Completing treatment for multidrug-resistant (MDR) tuberculosis (TB) may be
more challenging than completing first-line TB therapy, especially in resource-poor settings. …